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The First International Conference on the Stepped Wedge Trial
Design was hosted by the York Trials Unit, Department of Health Sci-
ences, University of York on 10 March 2016. The conference brought
together national and international delegates with experience, ex-
pertise or interest in this design which employs the incremental ran-
domised implementation of an intervention. The design has gained
popularity in the health, social and environmental sciences as a tool
to enable the evaluation of interventions/policies whilst being rolled
out gradually over time.
The conference speakers included eminent researchers at the fore-
front of the development of the design: Professor Richard Lilford
(University of Warwick), Professor Jim Hughes (University of Washing-
ton, USA), Dr Karla Hemming (University of Birmingham), Mr. Alan
Girling (University of Birmingham), and Professor Andrew Forbes
(Monash University, Australia).
The keynote speaker, Professor Richard Lilford opened the confer-
ence by giving the context for classic stepped wedge designs. This
was followed by nine oral and eight poster presentations where
practitioners, researchers and methodologists shared ideas, best
practice and challenges for the design, implementation and analysis
of the stepped wedge model. The conference was simultaneously
broadcast to remotely attending delegates from the UK and abroad
via dedicated online channels.
This supplement is a collection of the proceedings of the conference.
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Background
In six hospitals across Scotland, we are undertaking a study to evalu-
ate the efficacy and safety of implementation of an early rule out
diagnostic pathway using a high-sensitivity cardiac troponin to rule
out myocardial infarction on presentation in approximately 35,000
consecutive patients with suspected acute coronary syndrome.
Method
There will be three study phases each of six months duration: a valid-
ation phase using only the standard care pathway; a randomization
phase within which the six sites are randomized to start the interven-
tion at one of three time points 8 weeks apart; and an implementa-
tion phase calendar matched to the validation phase with all sites
using the new pathway. Patients with suspected myocardial infarc-
tion will be recruited as they present and then followed-up for
30 days. Sequential hypothesis testing will evaluate two co-primary
endpoints in an a-priori defined hierarchical order: (1) the proportion
of patients discharged from the Emergency Department (efficacy
endpoint), and (2) the proportion with myocardial infarction or death
at 30 days (safety endpoint test for non-inferiority).
Results
The trial is in progress and results are expected in 2018. To control
the overall Family-Wise Error Rate for the study we will use a serial
gatekeeping procedure.
Conclusions
The study design consists of a hybrid before-and-after and stepped
wedge trial design. The stepped wedge component enables us to
make cross-sectional comparisons as well as within-site comparisons;
the before-and-after component allows us to completely adjust for
seasonal effects and evaluate the intervention when it is fully em-
bedded into normal practice.
Acknowledgements
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Background
Stepped wedge trials have been used with increasing frequency in
health research.
For the cross-sectional form of this design, the within-cluster correl-
ation is typically accommodated in the analysis using a random inter-
cept linear mixed model, implying a constant correlation between
measurements of any two individuals in the same cluster no matter
how far apart in time they are measured.
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Methods
In this talk we propose an alternate correlation structure in which
the within-cluster correlation is allowed to vary depending on the
distance between measurements of individuals. In the special case of
exponential decay in the within-cluster correlation and an equal
number of subjects per period in each cluster, we present results for
the variance of treatment effect estimators for varying amounts of
decay addressing the following two questions:
(a) How does the precision in stepped wedge trials compare to
parallel-group cluster trials of the same size as the decay
varies?
(b)What are the consequences of this variation for sample size
planning?
Results and conclusions
Our results indicate that in certain design configurations a correlation
decay can have an impact on the variance of treatment effect esti-
mators, and hence on sample size and power.
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Background
The ENHANCE pilot trial aims to examine the feasibility and accept-
ability of an integrated approach to Long Term Condition (LTC) man-
agement by tackling the under-diagnosis and under-management of
osteoarthritis (OA) related pain and anxiety &/or depression in pa-
tients aged 45 years and over with other LTCs in primary care, using
a stepped wedge trial design. This abstract describes some of the
challenges faced in operationalising this trial design within general
practice, together with solutions that have been implemented.
Method
The intervention is an ‘ENHANCE’ LTC review, delivered by Practice
Nurses and in accordance with a stepped wedge design, has been
rolled out to four general practices (clusters) over time. Operationali-
sation challenges linked to the methods required for this trial design
have included; Scheduling of intervention training visits to fit with
randomisation schedules; Initial recruitment enthusiasm waning prior
to implementation of the intervention phase; Increase in trial delivery
requirements within clusters as the practice moves into the interven-
tion phase.
Results
In order to address these challenges the following solutions have
been implemented; a 2 week ‘wash out’ period to ensure clusters
make a smooth transition from control to intervention phase; Dedi-
cated trial management communication, forward planning and or-
ganisation of intervention training delivery; Identical study materials
across control and intervention phases; Communication and updates
around recruitment figures to ensure recruitment and adherence to
study design.
Conclusions
The stepped wedge design is an attractive option for delivering an
intervention within complex settings, however presents challenges
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Background
There is increasing methodological literature on design, sample size
calculations and analyses of stepped wedge trials (SWT). However,
the challenges encountered and potential solutions developed dur-
ing the implementation of SWTs are described less well. We aim to
share the experience of implementing the Thistle study, an on-going
SWT evaluating the effectiveness of a multi-professional obstetric
training programme across a health service.
Method
Our 36-month study consists of 12 Scottish maternity units randomised
in groups of four, to three intervention-steps of 6-months length.
Teams from each unit were trained in how to deliver the intervention.
The primary outcome (Apgar score) will be modelled using marginal lo-
gistic regression following the intention-to-treat principle (ITT).
Results
Departures from the randomisation plan were required to accommo-
date clinical constraints at four Maternity Units and ensure that they
were retained within the study. Heterogeneity in the timing and fre-
quency of local training post implementation was observed; some
units started prior to their allocated intervention step, some after,
and some completed their implementation over several steps. We
will use the wealth of routinely collected clinical and training data to
supplement the ITT-analysis with several sensitivity analyses to ac-
count for the actual intervention implementation.
Conclusions
Using a SWT design to evaluate the effectiveness of training inter-
vention in busy health care settings is complex. We have highlighted
problems regarding adherence to allocated step and the sensitivity
analyses we propose to tackle them. These findings will help guide
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Background
Recent articles have considered stepped wedge trials as part of a
broader class of cluster randomised trials where two or more inde-
pendent cross-sections are taken from each cluster at fixed times,
with all participants in any given cross-section in any given cluster re-
ceiving either the experimental or the control treatment. A unified
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approach to sample size calculation has been proposed in such
cases. However, a method for calculating sample size for closed
cohort cluster randomised trials, in which the same participants from
each cluster are followed repeatedly over time, has not yet been
described in the literature.
Methods
Here we show how common principles apply both to closed cohort
and to repeated cross-section cluster randomised trials, allowing a
unified framework for sample size calculation.
Results
Our general formulae are consistent with those previously described
in special cases such as stepped wedge, parallel group, and cross-
over designs, as well as being a natural extension of formulae for in-
dividually randomised trials with repeated assessments. Our frame-
work is more general than that of Hussey & Hughes in that we
include an additional parameter, which we call the cluster autocorrel-
ation, allowing participants from the same cluster sampled at differ-
ent times to be less well correlated than participants from the same
cluster sampled at the same time.
Discussion
We discuss the practical importance of the cluster autocorrelation
and other nuisance parameters, and the possible limitations of our
underlying statistical model. We also consider simulation as a tool for
assessing small-sample inaccuracies in asymptotic formulae.
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Background
Stratified randomisation has been recommended to balance the dis-
tribution of a cluster-level covariate over the arms of a stepped-
wedge study. The strata may reflect a simplified categorisation of the
covariate, and the approach is not available in studies with a single
cluster in each arm.
Methods
We assume that a potential effect-modifier – i.e. a covariate that inter-
acts with the intervention – can be used to generate a prior ordering of
the clusters. The size of a health-service unit is a popular candidate
here. An “anti-symmetric” randomisation scheme is described in which
clusters occupying equally extreme (but opposite) positions in the or-
dering are assigned either to the same arm of the design, or to the cor-
responding arm in the opposite half of the design. The procedure is
illustrated for some recent and ongoing studies.
Results
Under simplified modelling assumptions the resulting designs satisfy
two valuable properties of traditional stratified designs: (a) in an un-
adjusted analysis the estimate of the average treatment effect is un-
biased; (b) in an adjusted analysis the precision of the average effect
estimate is maximised. Simulation results are presented to compare the
bias for anti-symmetric designs with other randomisation schemes.
Conclusions
In a stepped-wedge study the potential for cluster-level confounders
to interfere with the treatment effect estimate is limited because
both treatment conditions occur within every cluster. The impact of
a potential effect-modifier can be mitigated using a restricted ran-
domisation scheme. Anti-symmetric randomisation offers advantages
over common-sense schemes which seek to balance the effect-
modifier over the treatment conditions. Unlike conventional stratifi-
cation this scheme is available even where no replication of the de-
sign is possible.
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Background
For the analysis of SWTs two main approaches have been proposed:
the vertical approach, where the intervention and the control groups
are compared within periods between successive switching points,
conditioning on time and the horizontal approach that takes into ac-
count of secular changes by including a fixed-effects indicator for
each time point. Here we propose an alternative model for horizontal
analyses, where cluster-specific secular trends are more flexibly mod-
elled through linear random terms.
Methods
The standard and alternative models are compared in a simulation
study. Specifically, we simulated binary and continuous outcomes in
a SWT with 20 clusters, adopting different choices regarding the
number of steps (5-10) and participants per cluster (25-50). We evalu-
ated 4 different scenarios: 1) stable trend, 2) increasing linear trend,
3) cluster-specific linear trends and 4) cluster-specific trends with
completely random patterns.
Results
In all scenarios the two models provide unbiased estimates of the ef-
fect of the intervention and similar efficiency in terms of root mean
square error and power. For SWTs with 10 steps, the alternative
model outperforms the standards one, with the latter showing
undercoverage in the third scenario, and generally lower conver-
gence rates. Both models suffer from quite low coverage in the
fourth, less plausible scenario.
Conclusions
Our method represents a valid alternative to the traditional analytical
approach for SWTs: while maintaining similar statistical power, our
approach shows better inferential and computational properties, pro-
vides additional information on cluster-specific trends and can flex-
ibly accommodate non-standard situations such as unequal time
measurements across clusters for generic SW designs.
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Background
Acute kidney injury (AKI) is a sudden reduction in kidney function
frequently observed during hospitalisation and associated with mul-
tiple negative outcomes that may be amenable to early intervention.
Tackling-AKI, a quality improvement project, aims to assess the ef-
fectiveness of a package of hospital-level interventions for AKI, using
patient-level outcomes collected pre- and post-intervention within a
stepped wedge study design.
Methods
All adults hospitalised overnight and sustaining AKI, referred to the
five participating UK hospitals, will be included.
The package of interventions comprises:
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 An electronic detection system to improve early recognition
of AKI
 An education programme to raise staff awareness and
knowledge in all major medical and surgical specialities
 A care bundle to improve the delivery of basic components of
AKI care
The study is taking place between December’14 and November’16,
with steps of three months. There will be two control periods, five
intervention steps with one hospital randomised to each step, and at
least one final follow-up step. Primary outcome is 30-day mortality
after AKI. Assuming an average of 540 AKI episodes per hospital per
time-period, 16 % 30-day mortality, α = 0.05 and ICC = 0.01, we will
have 80 % power to detect 20 % decrease in mortality.
Results
By February 2016, three of the five hospitals should have imple-
mented the intervention. Trial design and protocol will be de-
scribed, including barriers in data collection and adherence to
protocol.
Conclusions
This trial aims to test the effectiveness of the care package and will
provide evidence to determine the relevance of upscaling at national
UK level.
Acknowledgements
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Background
Quantifying the impact of bacterial density on transmission is import-
ant for understanding population level secondary effects of vaccines.
We developed a stepped wedge trial (SWT) to understand the effects
of Live Attenuated Influenza Vaccination (LAIV) on bacterial transmis-
sion by measuring impact of bacterial colonisation density on trans-
mission. We present sample size calculations for this SWT.
Materials and method
The design involved giving 2 year-old children LAIV, which transi-
ently increases S.pneumoniae (Sp) density in recipients, and measur-
ing bacterial transmission to household contacts. Index children will
be randomised to receive LAIV at the first or third of five fortnightly
home visits, when microbiological samples will be collected from
them and their contacts. Data relating carriage density and transmis-
sion, and clustering within families were unavailable, but evidence
suggests 60-70 % of pre-school children and >15 % of contacts are
Sp carriers. Extrapolation of census data suggested an average of
2.46 contacts per child.
Results
Detection of a 2-fold rise in transmission with 90 % power requires a
sample of 260 household contacts of children carrying Sp at the out-
set per study arm (total 520) assuming a normal approximation to
the binomial distribution. 500 index children and their families, yield-
ing 1230 contacts would be sufficient for endpoint detection, allow-
ing for 20 % dropout and ≥60 % carriage rate in the index (providing
590 contacts of informative index cases, 500x2.46x0.8x0.6). Social
contact data collected to stratify contacts by duration and proximity,
will be discussed at conference.
Conclusion
The lack of validated methods for sample size calculations of com-
plex SWT presents challenges.
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Background
Stepped wedge cluster randomised trial (SWCRT) designs are increas-
ingly popular for the evaluation of health interventions. However,
methodologies for appropriate sample size calculation have been lim-
ited to specific design scenarios [1, 2], namely, continuous and binary
outcomes. To our knowledge, no methodology is available yet specific-
ally to time-to-event data. This study aimed to evaluate sample size
and statistical power for SWCRTs that measure time-to-event data.
Methods
A model of the SWCRT design and time-to-event data was developed
and simulated in R [3]. Relevant design parameters were then
assessed for their impact on statistical power.
Results
Simulations showed that several parameters changed statistical
power while others had no observable effect in ways that are nor-
mally expected. Furthermore, the methodology was applied to esti-
mate the power of a published SWCRT.
Conclusions
We expect the proposed power estimation method to support the
efficient planning of future time-to-event SWCRTs. The method is suf-
ficiently flexible to allow further development by incorporating many
design issues encountered in real studies such as more expanded
models of time-to-event data and various censoring mechanisms.
References
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Background
The current methodology for sample size calculation for stepped-
wedge cluster randomised trials (SW-CRTs) is based on the assump-
tion of the clusters being of equal size. However, as is often the case
in CRTs, the clusters in SW-CRTs are likely to vary in size which in
CRTs of other designs leads to a reduction in power. The effect of an
imbalance in cluster sizes on SW-CRTs was not known, nor what an
appropriate adjustment to the sample size should be.
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Methods
We proposed three adjusted design effects (DEs) for use in the calcu-
lation of the sample size for SW-CRTs with varying degrees of imbal-
ance in cluster size, based on those suggested for use in CRTs with
unequal cluster sizes. A simulation study was conducted which inves-
tigated the effect of unequal cluster sizes on the power of SW-CRTs,
when the sample size was calculated using both the standard
method and the three proposed adjusted DEs.
Results
An imbalance in cluster size was not found to significantly affect the
power of a SW-CRT, and the proposed adjusted DEs generally re-
sulted in trials that were severely over-powered.
Conclusions
We recommend that the standard method of sample size calculation
for SW-CRTs be used when any imbalance in cluster size is expected
to be small. When there is likely to be a large imbalance in cluster
size it is recommended that simulations be used to determine if add-
itional clusters are needed.
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Background
A stepped wedge (SW) design, comparing standard treatment (A)
with a new treatment (B), can be thought of as allocating units to L
sequences of treatments, with each sequence divided into T succes-
sive periods. In the usual SW design the L and T are such that L = T-1.
It may be infeasible to run a trial with many treatment periods but at
the same time the number of units, N, to be allocated will exceed T-
1, so multiple units are allocated to each sequence. The units are
usually clusters, such as general practices, not of equal size. The
problem then arises about how best to allocate a set of N units, of
known sizes, n1,n2,…,nN, to the L sequences.
Method
Assuming the standard model proposed by Hussey & Hughes [1], an ex-
pression for the variance, V, of the estimator of the treatment effect, is de-
rived using methods from optimal design theory. The optimal allocation
of the units to sequences can be found by minimizing the value of V.
Results
Exact results are available when the intra-class correlation (ICC) is ex-
treme. For more realistic values and modest numbers of clusters (<
about 10), the optimal design can be found using exhaustive
searches and these suggest a smooth transition between the forms
of the design for extreme ICCs. Approaches using suitable approxi-
mations are needed for larger numbers of clusters.
Conclusion
With SW designs with clusters of varying sizes attention should be
paid to how these are allocated to the sequences in the design.
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Background
In general, recruitment is a challenge for trials of secondary preven-
tion after stroke in the UK. Certainly it is an ongoing challenge for
the REstart or STop Antithrombotics Randomised Trial (RESTART): a
multicentre trial in stroke prevention.
Method
We are currently conducting a stepped wedge cluster randomised
trial of a complex intervention to boost recruitment at 72 active sites in
RESTART. The intervention involves a recruitment co-ordinator who is (1)
providing software for hospital sites to extract lists of their own patients
from stroke audit data sources using criteria customised to the trial eligi-
bility criteria, (2) training investigators at each site via a telephone ‘recruit-
ment review’ to use the reports and approach prevalent stroke survivors,
and (3) following-up the recruitment review 6 months later. The primary
outcome of site recruitment rate will be compared before and after im-
plementation of the recruitment reviews in a negative binomial mixed
model, adjusting for site, time since start of study, and season.
Results
Stratified block randomisation was used to randomly allocate the 72
sites to one of 12 specific timings when they would start to imple-
ment the intervention, stratified by hospital location (Scotland versus




This is an example of a study-within-a-trial with a closed cohort
stepped wedge design whereby all sites begin in the control state
and the monthly recruitment rate is measured until after all sites
have been allocated to the intervention.
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Background
Many stepped wedge trials are analysed using a mixed effect model
with a random effect for cluster but there is little understanding of
the implications of misspecifying this model. We investigated the es-
timated intervention effect and its standard error when time period
and intervention effects varied between clusters but were treated as
fixed effects in the analysis model.
Methods
We performed a simulation study of a stepped wedge trial with three
groups and two time periods: during the first period one group had
the intervention, and during the second two groups had the inter-
vention. We simulated combinations of time period and intervention
effects being common to all or varying between clusters. These
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simulated data were analysed with a mixed effect model with a ran-
dom effect for cluster only, or with additional random effects for
time period or intervention.
Results
Omitting random effects for time period or intervention in the
analysis model when variation between clusters was present in these
effects led to standard errors which were much too small and type 1
error rates of up to 94 %. Estimated intervention effects remained
unbiased with all analysis models. Inclusion of a random effect for ei-
ther time period or intervention effect in the analysis model im-
proved the type 1 error rate when there was variability between
clusters of either effect present.
Conclusions
Stepped wedge trial analyses must account for variability between
clusters in time period and intervention effects in order to appropri-
ately reflect the precision of the intervention effect estimate.
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Background
Stepped wedge design trials, in which each cluster crosses-over uni-
directionally from a control to an intervention condition, are typically
used to evaluate a single intervention. We examined variations of
stepped wedge designs for evaluating multiple interventions.
Methods
We describe four variants of a stepped wedge design trial with two
interventions: concurrent design (two single intervention stepped
wedge trials implemented simultaneously), replacement (unidirec-
tional cross-over from control to first intervention to second interven-
tion), supplementation (unidirectional cross-over from control to first
intervention to combined intervention), and factorial designs (half
the clusters cross-over from control to first intervention to combined
intervention and half cross-over from control to second intervention
to combined intervention). Analyses are conducted comparing the
precision of the estimated intervention effects for the different
designs.
Results
Under the Hussey and Hughes (2007) [1] model for stepped wedge
designs, the concurrent, supplementation, and factorial variants pro-
vide equal precision for estimating the treatment effects, while in the
replacement design the first introduced intervention is generally esti-
mated more precisely than the second intervention. Surprising and
nonintuitive changes in the precision of the intervention effect esti-
mates are observed when additional observation time intervals are
included in these designs. Results may depend on the model chosen
for analysis.
Conclusion
These variations offer methods for studying two interventions using
a stepped wedge design. Selection of a design should be driven pri-
marily by the research question with additional consideration given
to the trade-off between trial duration and number of clusters, as
well as restrictions for concurrent or sequential implementation
based on intervention characteristics.
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Cluster Randomized Trials. Contemporary Clinical Trials, 28:182-191,
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Background
Stepped wedge cluster randomised trials (SW-CRT) are novel study
designs increasingly used to evaluate policy or service delivery treat-
ments. There is a dearth of literature on how to analyse these stud-
ies. A recent systematic review identified that 67 % of published SW-
CRTs failed to adjust for secular trends at the analysis stage.
Methods
We set out a framework for how results from cross-sectional SW-CRTs
should be analysed. We recommend that as with all cluster trials, al-
lowance should be made for the clustered nature of the data. In
addition, adjustment should be made for underlying secular trends,
irrespective of whether these are identified as statistically significant.
We allow for different secular trends in different cluster stratum; an
allowance for treatment effect heterogeneity across clusters; variation
in the treatment effect over time since introduction into the cluster;
and include an inter-period as well as an inter-cluster correlation.
Results
We illustrate these analysis methods using a case study. In this case
study the unadjusted effect of the treatment suggests that the treat-
ment is beneficial. However, we demonstrate evidence of an under-
lying secular trend with the outcome improving in control clusters
over time. As a result, after adjustment for secular trends, the ad-
justed treatment effect reveals no effect of the treatment and may
even suggest harm. When allowing for a lag effect, this difference
was even more pronounced. Other model variations considered had
no substantial impact on conclusions in the example.
Conclusion
When interpreting and analysing a SW-CRT the estimated treatment
effect should be adjusted for secular trends. This adjusted treatment
effect can be very different to the unadjusted treatment effect. Fur-
thermore, the analysis methods are not assumption free and the ap-
propriateness of these assumptions should be investigated.
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